Adherence to preventive medications: Predictors and outcomes in the diabetes prevention program

Diabetes Care

Volumn 29, Issue 9, 2006, Pages 1997-2002

  Walker, Elizabeth A ^a,e   Molitch, Mark ^b   Kramer, M Kaye ^c   Kahn, Steven ^d   Ma, Yong ^e   Edelstein, Sharon ^e   Smith, Kellie ^f   Johnson, Mariana Kiefer ^b   Kitabchi, Abbas ^g   Crandall, Jill ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; METFORMIN; PLACEBO;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ETHNOLOGY; FEMALE; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; INCOME; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PILL; PREDICTION; PREVENTIVE MEDICINE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SEX DIFFERENCE; STATISTICAL ANALYSIS; STRUCTURED INTERVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; METFORMIN; MIDDLE AGED; ODDS RATIO; PATIENT COMPLIANCE; PROGNOSIS; TREATMENT OUTCOME;

EID: 33845346826     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0454     Document Type: Article

References (19)

1. The Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
2. The Diabetes Prevention Program Research Group: Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program: effect of lifestyle intervention and metformin. Diabetes 54:2404-2414, 2005
3. DiMatteo MR: Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42:200-209, 2004
4. Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CR, Sereika SM, Doswell WM: Adherence in chronic disease. Annu Rev Nurs Res 18:48-90, 2000
5. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 353:487-497, 2005
6. Donnan PT, MacDonald TM, Morris AD, the DARTS/MEMO Collaboration: Adherence to prescribed oral hypoglycemic medication in a population of patients with type 2 diabetes: a retrospective study. Diabet Med 19:279-284, 2002
7. Dunbar J: Predictors of patient adherence: patient characteristics. In The Handbook of Health Behavior Change. Shumaker S, Schon EB, Okene JK, Eds. New York, Springer, 1990, p. 348-360
8. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL: Antecedents of adherence to medical recommendations: results from the medical outcomes study. J Behav Med 15:447-468, 1992
9. DiMatteo MR, Sherbourne CD, Hays RD, Ordway L, Kravitz RL, McGlynn EA, Kaplan S, Rogers WH: Physicians' characteristics influence patients' adherence to medical treatment: results from the medical outcomes study. Health Psych 12:93-102, 1983
10. Diggle PJ, Liang K-Y, Zeger SL: Analysis of Longitudinal Data. New York, Oxford University Press, 1994
11. Holm S: A simple sequentially rejective Bonferroni test procedure. Scandinavian J Statistics 6:65-70, 1979
12. Kirpichnikov D, McFarlane SI, Sowers JR: Metformin: an update. Ann Intern Med 137:25-33, 2002
13. The Diabetes Prevention Program Research Group: The Diabetes Prevention Program: description of the lifestyle intervention. Diabetes Care 25:2165-2171, 2002
14. Vik SA, Maxwell CJ, Hogan DB: Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 38:303-312, 2004
15. Ryan AA: Medication compliance and older people: a review of the literature. Int J Nurs Stud 36:153-162, 1999
16. The Coronary Drug Research Project Research Group: Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med 303:1038-1041, 1980
17. Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, Ransohoff DF, Sindelar J: Treatment adherence and risk of death after a myocardial infarction. Lancet 336:542-545, 1990
18. DiMatteo RM, Giordani PJ, Lepper H, Croghan TW: Patient adherence and medical treatment outcomes. Med Care 40:794-811, 2002
19. McDonald HP, Garg AX, Haynes RB: Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 288:2868-2879, 2002